Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the completion of a ? 30 million Series B financing round to support the enrollment of the PROTEMBO Investigational Device Exemption (IDE).
Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.